vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and Mayville Engineering Company, Inc. (MEC). Click either name above to swap in a different company.
Axsome Therapeutics, Inc. is the larger business by last-quarter revenue ($196.0M vs $134.3M, roughly 1.5× Mayville Engineering Company, Inc.). Mayville Engineering Company, Inc. runs the higher net margin — -3.2% vs -14.6%, a 11.3% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 10.7%). Mayville Engineering Company, Inc. produced more free cash flow last quarter ($10.2M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs -8.8%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
Mayville Engineering Company, Inc. is a U.S.-headquartered leading manufacturer of metal components, fabricated assemblies, and custom engineered solutions. It serves OEM clients across agriculture, construction, transportation, defense, and power sports markets, offering end-to-end services from prototyping to high-volume production for North America.
AXSM vs MEC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $134.3M |
| Net Profit | $-28.6M | $-4.4M |
| Gross Margin | — | 6.8% |
| Operating Margin | -13.8% | -4.1% |
| Net Margin | -14.6% | -3.2% |
| Revenue YoY | 65.0% | 10.7% |
| Net Profit YoY | 61.9% | -127.3% |
| EPS (diluted) | $-0.55 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $196.0M | $134.3M | ||
| Q3 25 | $171.0M | $144.3M | ||
| Q2 25 | $150.0M | $132.3M | ||
| Q1 25 | $121.5M | $135.6M | ||
| Q4 24 | $118.8M | $121.3M | ||
| Q3 24 | $104.8M | $135.4M | ||
| Q2 24 | $87.2M | $163.6M | ||
| Q1 24 | $75.0M | $161.3M |
| Q4 25 | $-28.6M | $-4.4M | ||
| Q3 25 | $-47.2M | $-2.7M | ||
| Q2 25 | $-48.0M | $-1.1M | ||
| Q1 25 | $-59.4M | $20.0K | ||
| Q4 24 | $-74.9M | $16.0M | ||
| Q3 24 | $-64.6M | $3.0M | ||
| Q2 24 | $-79.3M | $3.8M | ||
| Q1 24 | $-68.4M | $3.2M |
| Q4 25 | — | 6.8% | ||
| Q3 25 | — | 11.0% | ||
| Q2 25 | — | 10.3% | ||
| Q1 25 | — | 11.3% | ||
| Q4 24 | — | 8.9% | ||
| Q3 24 | — | 12.6% | ||
| Q2 24 | — | 13.6% | ||
| Q1 24 | — | 13.0% |
| Q4 25 | -13.8% | -4.1% | ||
| Q3 25 | -27.0% | 0.0% | ||
| Q2 25 | -24.5% | 0.1% | ||
| Q1 25 | -46.9% | 1.2% | ||
| Q4 24 | -61.1% | 19.0% | ||
| Q3 24 | -59.8% | 4.2% | ||
| Q2 24 | -89.5% | 5.0% | ||
| Q1 24 | -89.7% | 4.7% |
| Q4 25 | -14.6% | -3.2% | ||
| Q3 25 | -27.6% | -1.9% | ||
| Q2 25 | -32.0% | -0.8% | ||
| Q1 25 | -48.9% | 0.0% | ||
| Q4 24 | -63.1% | 13.2% | ||
| Q3 24 | -61.7% | 2.2% | ||
| Q2 24 | -91.0% | 2.3% | ||
| Q1 24 | -91.1% | 2.0% |
| Q4 25 | $-0.55 | $-0.22 | ||
| Q3 25 | $-0.94 | $-0.13 | ||
| Q2 25 | $-0.97 | $-0.05 | ||
| Q1 25 | $-1.22 | $0.00 | ||
| Q4 24 | $-1.54 | $0.76 | ||
| Q3 24 | $-1.34 | $0.14 | ||
| Q2 24 | $-1.67 | $0.18 | ||
| Q1 24 | $-1.44 | $0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | $1.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $88.3M | $240.7M |
| Total Assets | $689.8M | $563.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $322.9M | $1.5M | ||
| Q3 25 | $325.3M | $1.2M | ||
| Q2 25 | $303.0M | $206.0K | ||
| Q1 25 | $300.9M | $183.0K | ||
| Q4 24 | $315.4M | $206.0K | ||
| Q3 24 | $327.3M | $178.0K | ||
| Q2 24 | $315.7M | $314.0K | ||
| Q1 24 | $331.4M | $314.0K |
| Q4 25 | $88.3M | $240.7M | ||
| Q3 25 | $73.7M | $244.8M | ||
| Q2 25 | $73.1M | $246.8M | ||
| Q1 25 | $53.2M | $250.0M | ||
| Q4 24 | $57.0M | $251.8M | ||
| Q3 24 | $92.9M | $238.4M | ||
| Q2 24 | $102.9M | $238.1M | ||
| Q1 24 | $144.0M | $234.0M |
| Q4 25 | $689.8M | $563.6M | ||
| Q3 25 | $669.3M | $585.6M | ||
| Q2 25 | $639.8M | $433.7M | ||
| Q1 25 | $596.7M | $447.7M | ||
| Q4 24 | $568.5M | $445.6M | ||
| Q3 24 | $561.5M | $466.0M | ||
| Q2 24 | $548.2M | $488.2M | ||
| Q1 24 | $545.7M | $499.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | $13.4M |
| Free Cash FlowOCF − Capex | $-18.7M | $10.2M |
| FCF MarginFCF / Revenue | -9.6% | 7.6% |
| Capex IntensityCapex / Revenue | 0.0% | 2.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | $26.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.7M | $13.4M | ||
| Q3 25 | $1.0M | $1.9M | ||
| Q2 25 | $-32.4M | $15.0M | ||
| Q1 25 | $-43.4M | $8.3M | ||
| Q4 24 | $-26.2M | $38.0M | ||
| Q3 24 | $-18.6M | $17.9M | ||
| Q2 24 | $-30.1M | $23.3M | ||
| Q1 24 | $-53.5M | $10.6M |
| Q4 25 | $-18.7M | $10.2M | ||
| Q3 25 | $988.0K | $-1.1M | ||
| Q2 25 | $-32.4M | $12.5M | ||
| Q1 25 | $-43.7M | $5.4M | ||
| Q4 24 | $-26.2M | $35.6M | ||
| Q3 24 | $-18.7M | $15.1M | ||
| Q2 24 | $-30.2M | $19.2M | ||
| Q1 24 | $-53.6M | $7.8M |
| Q4 25 | -9.6% | 7.6% | ||
| Q3 25 | 0.6% | -0.8% | ||
| Q2 25 | -21.6% | 9.5% | ||
| Q1 25 | -36.0% | 4.0% | ||
| Q4 24 | -22.1% | 29.4% | ||
| Q3 24 | -17.9% | 11.1% | ||
| Q2 24 | -34.6% | 11.7% | ||
| Q1 24 | -71.4% | 4.9% |
| Q4 25 | 0.0% | 2.4% | ||
| Q3 25 | 0.0% | 2.1% | ||
| Q2 25 | 0.0% | 1.8% | ||
| Q1 25 | 0.3% | 2.2% | ||
| Q4 24 | 0.0% | 1.9% | ||
| Q3 24 | 0.1% | 2.1% | ||
| Q2 24 | 0.1% | 2.5% | ||
| Q1 24 | 0.1% | 1.7% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 416.65× | ||
| Q4 24 | — | 2.38× | ||
| Q3 24 | — | 6.03× | ||
| Q2 24 | — | 6.15× | ||
| Q1 24 | — | 3.28× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXSM
Segment breakdown not available.
MEC
| Fabrication | $72.2M | 54% |
| Construction And Access | $19.2M | 14% |
| Tubes | $16.2M | 12% |
| Other Market | $11.9M | 9% |
| Agriculture | $7.7M | 6% |
| Military | $6.7M | 5% |
| Outdoor Sports | $1.7M | 1% |
